“Transforming Patient Care with Molecular Testing: Current and Future Impacts” is a free educational program that will be held on Tuesday, July 28, from 5:30 pm to 7:30 pm in the International Ballroom North at the Hyatt Regency Atlanta Hotel.
Hosted by Roche Diagnostics, Indianapolis, the event will feature talks from Mark Stoler, MD, professor emeritus of pathology, cytology, and gynecology at the University of Virginia, and Lee Shulman, MD, chief of the division of obstetrics and gynecology–clinical genetics at Feinberg School of Medicine at Northwestern University.
Stoler will discuss significant variations in the cytologic and histologic interpretations of cervical specimens, and how the addition of molecular testing can improve the accuracy of screening and diagnosis of cervical neoplasia. Shulman will trace the development of current cervical disease surveillance algorithms and their significant impact on reducing the morbidity and mortality associated with cervical cancer.
Also on the agenda is a presentation titled “A Clinician’s Perspective on Improving Cervical Screening with Molecular Testing,” given by Catherine M. Behrens, MD, PhD, a consultant for Roche Molecular Systems.
Following the presentations will be a reception for social networking and the opportunity for further conversation with the speakers.
To register for the event, visit AACC.
